Thrombosis and cancer: implications beyond Trousseau.
Kakkar
A K
AK
Centre for Surgical Sciences, St Bartholomew's and The London Hospitals Medical School, Thrombosis Research Institute, London, UK. akkakkar@tri-london.ac.uk
Levine
M N
MN
D000970:Antineoplastic Agents / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D006493:Heparin / Q000378:metabolism / Q000627:therapeutic use; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use; D006801:Humans; D009369:Neoplasms / Q000150:complications* / Q000175:diagnosis*; D010919:Placebos; D013997:Time Factors; D016896:Treatment Outcome; D020246:Venous Thrombosis / Q000150:complications* / Q000175:diagnosis*
D000970:Antineoplastic Agents; D006495:Heparin, Low-Molecular-Weight; D010919:Placebos; D006493:Heparin